WELLS FARGO & COMPANY/MN - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,923,094
-29.5%
155,707
+68.9%
0.00%0.0%
Q2 2023$8,398,965
+20.6%
92,195
-12.7%
0.00%0.0%
Q1 2023$6,966,563
+695.1%
105,618
+523.3%
0.00%
Q4 2022$876,226
-68.9%
16,945
-59.0%
0.00%
Q3 2022$2,821,000
+295.1%
41,298
+161.3%
0.00%
Q2 2022$714,000
-66.1%
15,802
-61.8%
0.00%
-100.0%
Q1 2022$2,105,000
-30.3%
41,419
-35.2%
0.00%0.0%
Q4 2021$3,022,000
+81.3%
63,925
+26.4%
0.00%
Q3 2021$1,667,000
-27.1%
50,589
+39.8%
0.00%
-100.0%
Q2 2021$2,287,000
+431.9%
36,199
+260.7%
0.00%
Q1 2021$430,000
-84.5%
10,037
-79.3%
0.00%
-100.0%
Q4 2020$2,770,000
+246.7%
48,423
+83.0%
0.00%
Q3 2020$799,000
-39.7%
26,464
-34.8%
0.00%
Q2 2020$1,326,000
+60.7%
40,600
+31.9%
0.00%
Q1 2020$825,000
-54.0%
30,772
-47.4%
0.00%
Q4 2019$1,793,000
+63.7%
58,545
+28.7%
0.00%
Q3 2019$1,095,000
-1.8%
45,478
+3.4%
0.00%
Q2 2019$1,115,000
+140.8%
43,998
+85.4%
0.00%
Q1 2019$463,000
+37.4%
23,726
-7.1%
0.00%
Q4 2018$337,000
+6.0%
25,528
+42.5%
0.00%
Q3 2018$318,000
-14.1%
17,911
+6.5%
0.00%
Q2 2018$370,000
+172.1%
16,823
+173.6%
0.00%
Q1 2018$136,000
+288.6%
6,149
+285.3%
0.00%
Q4 2017$35,0001,5960.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders